Back to News
Market Impact: 0.2
Wall Street Analysts Think BioCryst (BCRX) Could Surge 108.21%: Read This Before Placing a Bet
Source: zacks.com
Analyst EstimatesAnalyst InsightsInvestor Sentiment & PositioningCompany Fundamentals
Wall Street’s average price target for BioCryst (BCRX) implies 108.2% upside. The article flags that price-target methodology is questionable, but notes improving earnings estimate revisions could support the stock’s upside narrative.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
BCRX0.25
More News
- ‘If nothing is done, it’s almost inevitable’: Ukraine’s Yuriy Ryzhenkov on why steelmaking is on the brink of collapse as Russian bombing intensifies
- Why is LG Innotek stock plunging today?
- RBI Tightens Rupee Defense as Pricey Crude, Foreign Outflows Bite: USD/INR
- TotalEnergies, KKR expand U.S. solar venture with 700 MW addition
- Vår Energi cuts 2026 output forecast; Q3 production at 369,000 boepd
- TSMC expected to report sixth straight quarter of record profit thanks to AI boom